Immune and hormone markers in acute coronary syndrome prognosis
Part of Heart & circulation clinical trials.
This trial looks at how your body's immune system, hormones, and inflammation affect recovery after a heart attack or unstable angina. It may help doctors better predict outcomes for people with acute coronary syndrome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 or older and have been admitted to the hospital with a heart attack or unstable angina (acute coronary syndrome).
- You agree to take part in the study and sign a consent form.
- You do not have cancer, an autoimmune or chronic inflammatory disease (like rheumatoid arthritis or lupus).
- You do not have an allergy, parasitic infection, asthma, or a condition with high eosinophil levels.
- You are not pregnant, and you do not have severe kidney or liver disease, or a life expectancy of less than 6 months.
- You have not had a heart attack in the last month and are not on long-term corticosteroid therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood markers (inflammation and heart damage indicators) in patients who have just had a heart attack or severe chest pain. Researchers want to understand how these markers relate to heart function to improve patient care.
This study is checking if a simple blood test (hs-CRP to albumin ratio) can help predict outcomes in people who have had a heart attack or unstable angina but are not getting an immediate balloon/stent procedure. It aims to use inflammation markers to guide better care.
This study examines blood samples from people with different types of coronary artery disease to understand the condition better. It may help doctors learn how to treat heart problems in the future.
This registry study follows people diagnosed with acute coronary syndrome to see what drug treatments lead to better health outcomes. It may help doctors understand which treatments work best in real-world care.
This study looks at two simple blood test measures to see if they can predict how severe coronary artery disease is in people having a heart attack. It aims to find better ways to assess risk right when you arrive at the hospital.
This trial studies how people do after a heart attack (or related heart injury) and may test treatments that could improve outcomes. If you’re an adult and recently had this heart event, you may be able to join after discussing consent.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.